Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Narcolepsy: treatment issues.

Thomas Roth1

  • 1Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, MI 48202, USA. Troth1@hfhs.org

The Journal of Clinical Psychiatry
|December 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying major life events associated with insomnia disorder: Stressors that disrupt safety, stability, and identity.

Sleep health·2026
Same author

Discrepancies Between Subjective and Objective Evaluation of Sleep: Potential Marker for Mild Cognitive Impairment.

Sleep medicine research·2026
Same author

Solubility, speciation and thermodynamics of Fe in reducing aqueous KCl solutions.

RSC advances·2025
Same author

Once-Nightly Sodium Oxybate Meets American Academy of Sleep Medicine Criteria for Treatment of Narcolepsy.

Journal of sleep research·2025
Same author

A randomized controlled trial of telemedicine CBTI and PUMAS for prenatal insomnia: Reducing nocturnal cognitive arousal is a treatment mechanism for alleviating insomnia and depression during pregnancy.

Sleep medicine·2025
Same author

A Mechanistic study assessing difficulty discontinuing chronic hypnotic use.

Psychopharmacology·2025
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Narcolepsy treatment focuses on cataplexy and excessive daytime sleepiness (EDS). Sodium oxybate treats both symptoms, while modafinil and dextroamphetamine are approved for EDS.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Pharmacology

Background:

  • Narcolepsy management typically targets distinct symptoms: cataplexy and excessive daytime sleepiness (EDS).
  • Current treatments for cataplexy include antidepressants (venlafaxine, imipramine, protriptyline) and sodium oxybate.
  • Monoamine oxidase inhibitors are less commonly used for cataplexy.

Purpose of the Study:

  • To review the pharmacologic management strategies for narcolepsy.
  • To outline FDA-approved medications for excessive daytime sleepiness (EDS).
  • To compare the efficacy of treatments for narcolepsy symptoms.

Main Methods:

  • Literature review of pharmacologic treatments for narcolepsy.
  • Analysis of FDA-approved medications for narcolepsy symptoms.

Related Experiment Videos

  • Comparison of treatment efficacies based on existing data.

    • Main Results:

    • Antidepressants and sodium oxybate are primary treatments for cataplexy.
    • Four medications are FDA-approved for EDS: dextroamphetamine, methylphenidate, modafinil, and sodium oxybate.
    • Sodium oxybate is unique in treating both cataplexy and EDS.
    • Modafinil and sodium oxybate demonstrate comparable long-term efficacy for EDS.

    Conclusions:

    • Pharmacologic approaches to narcolepsy address symptoms individually.
    • Sodium oxybate offers a dual-action treatment for both cataplexy and EDS.
    • Modafinil and sodium oxybate are effective long-term options for managing EDS in narcolepsy.